PRP wrist study pulled before it even started
NCT ID NCT03830775
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study planned to test whether a platelet-rich plasma (PRP) injection, made from a patient's own blood, could help heal a common wrist ligament injury called TFCC tear. The trial was designed to compare PRP against a placebo in adults with MRI-confirmed tears. However, the study was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- platelet-rich plasma (PRP) injection
- What this could lead to
- If it had worked, this could have pointed toward a non-surgical treatment for common wrist ligament injuries.
- What could go wrong
- The trial was withdrawn before enrolling anyone, so no data exist. PRP is still unproven for this condition, and results from other joints vary widely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Started
-
Oct 2020
- Expected to finish
-
Dec 2023
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: 1. Adult patients consenting for wrist injection, who additionally consent to participate in this study. 2. MRI which indicates a TFCC tear or Scapho-lunate ligament tear (SL) Exclusion criteria: 1. Patients who do not choose to participate in the study or who do not wish to have an injection 2. Patients who want an injection - but do not want to be randomized. 3. Patients who do not complete one of the follow up documentations. 4. Patients who would like to know their injection (unblinded) may be informed but the investigators will still attempt to collect data as per protocol.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRP are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lola Norton
El Paso, Texas, 79903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Double scan strategy aims to catch wrist tears that single MRI misses
- Can threads or plasma smooth out old scars?
- AI mouse could give Pain-Free computing to millions with hand injuries
- New wrist scanner could slash radiation and speed up 3D imaging
- Could stem cells from shoulder tissue boost rotator cuff healing?
- ER wrist reset may be unnecessary for some breaks